WELCOME TO

A fresh approach to Life Science PR & Marketing
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:

PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events

Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches

Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production

Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.

EVENTS
-
Scientific Superpower Conference 2025
-
Cambridge Wide Open Week
-
BioSeed Summer 2025
-
BIA TechBio X Cambridge
Closed Loop Medicine appoints Kate Woolland as CEO
Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies London, UK – May 20, 2025: Closed Loop Medicine Ltd. (“CLM”), a leader [...]
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion Cambridge, UK, 20 May 2025: CN Bio, a leading provider of [...]
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides, Co-founder and Director, Milner Therapeutics [...]